
Burning Rock Biotech Ltd
NASDAQ:BNR

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BNR's stock price target?
Not Available
BNR doesn't have any price targets made by Wall Street professionals.
What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
49%
For the last 6 years the
compound annual growth rate for
Burning Rock Biotech Ltd's revenue is
16%.
The projected
CAGR
for the next 2 years is
49%.